JNK1 (MAPK8), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-JNK1 (MAPK8), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | JNK1 (MAPK8), Human |
| Clone | REAL1128 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | n/a |
| Format | fluorescein (FITC) conjugate |
| Size | 200 µL |
| Concentration | n/a |
| Applications | MICS (MACSima Imaging Cyclic Staining), Immunohistochemistry, Immunofluorescence |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | JNK1 (MAPK8) Antibody, anti-human, FITC, REAdye_lease™. Clone REAL1128 is an antibody fragment derived from the full JNK1 (MAPK8) antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL 1128 recognizes JNK1 (MAPK8), also known as c-Jun N-terminal kinase 1 belongs to the MAPK superfamily of stress-activated protein kinasesis. It is involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. JNK1/MAPK8 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). |
| Immunogen | n/a |
| Other Names | c-Jun N-terminal kinase 1, MAP kinase 8, JNK-46, SAPK1c, SAPK1, PRKM8 |
| Gene, Accession # | n/a |
| Catalog # | 130-128-466 |
| Price | $400 |
| Order / More Info | JNK1 (MAPK8), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Lorenzati, M. et al. (2021) c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination. Sci Rep 11: 7264. | Liu, J. et al. (2019) JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression. Nat Commun. 10 (1): 2148-doi 10.103. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies